“Metabolic syndrome and cardiovascular risk in patients with breast cancer undergoing adjuvant endocrine therapy”, Acervo Saúde, vol. 26, no. 3, p. e23208, Mar. 2026, doi: 10.25248/reas.e23208.2026.